Fig. 2: Overall survival and progression-free survival of the entire study population. | Bone Marrow Transplantation

Fig. 2: Overall survival and progression-free survival of the entire study population.

From: Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

Fig. 2

Overall survival of the overall population (a); Simon–Makuch survival curves comparing the transplant vs not transplant cohorts (b). Progression-free survival of the overall population (c); Simon-Makuch progression-free survival curves comparing the transplant vs not transplant cohorts (d). OS overall survival, PFS progression-free survival.

Back to article page